Published in Crit Care on February 28, 2014
Dialysis with high-flux membranes significantly affects plasma levels of neutrophil gelatinase-associated lipocalin. Crit Care (2016) 0.91
Effective and timely evaluation of pulmonary congestion: qualitative comparison between lung ultrasound and thoracic bioelectrical impedance in maintenance hemodialysis patients. Medicine (Baltimore) (2015) 0.83
Association of Perioperative Plasma Neutrophil Gelatinase-Associated Lipocalin Levels with 3-Year Mortality after Cardiac Surgery: A Prospective Observational Cohort Study. PLoS One (2015) 0.79
Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability. Dis Markers (2015) 0.77
Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane! Crit Care (2016) 0.75
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all. Crit Care (2014) 0.75
Role of Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis and Early Treatment of Acute Kidney Injury in a Case Series of Patients with Acute Decompensated Heart Failure: A Case Series. Cardiol Res Pract (2016) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ (2003) 10.80
Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.99
Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol (2007) 4.99
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem (2001) 3.48
The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med (2011) 3.20
Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics (1997) 3.16
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol (2009) 3.01
Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int (2007) 2.93
Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med (2009) 2.53
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int (2011) 2.52
The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol (2008) 2.08
Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J (1999) 1.96
N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int (2007) 1.95
Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol (2010) 1.73
Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail (2008) 1.67
Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease. Clin Chem (2009) 1.64
The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am J Clin Pathol (2010) 1.60
Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Eur J Heart Fail (2011) 1.48
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med (2012) 1.32
Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res (2009) 1.31
Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem (2004) 1.25
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine (2011) 1.19
Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease. Ren Fail (2008) 1.16
Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein. Am J Physiol Renal Physiol (2010) 1.12
Albuminuria increases cystatin C excretion: implications for urinary biomarkers. Nephrol Dial Transplant (2011) 1.08
Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study. Endocrine (2009) 1.03
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Res Clin Pract (2012) 1.01
Establishment of a reference interval for urinary neutrophil gelatinase-associated lipocalin. Ann Clin Biochem (2012) 0.99
Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure. Int J Cardiol (2011) 0.98
Brain natriuretic peptide and N-terminal proBNP in chronic haemodialysis patients. Nephron Clin Pract (2006) 0.95
Noninvasive methods for the measurement of total renal function. Nephron (1981) 0.92
A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections. Am J Med (2012) 0.90
The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome. Blood Purif (2004) 0.89
Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients. Clin Transplant (2009) 0.88
The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury. Blood Purif (2013) 0.87
Are natriuretic peptides useful biomarkers in dialysis patients? Perit Dial Int (2007) 0.86
Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care (2012) 0.86
Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation. Transplant Proc (2009) 0.86
Cystatin C and neutrophil gelatinase-associated lipocalin as markers of renal function in pediatric heart transplant recipients. Pediatr Transplant (2011) 0.80
Measurement of glomerular filtration rate in man using DTPA-99mTc. Nephron (1979) 0.79
Renal biomarkers for assessment of kidney function in renal transplant recipients: how do they compare? Int Urol Nephrol (2012) 0.78
The case of Sarno River (Southern Italy): effects of geomorphology on the environmental impacts. Environ Sci Pollut Res Int (2006) 1.02
In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients. Nephrol Dial Transplant (2005) 0.96
A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. Blood Purif (2011) 0.83
Geomorphological evolution and environmental reclamation of Fusaro Lagoon (Campania Province, southern Italy). Environ Int (2004) 0.82
Effects of the incubation in vitro with sorbents on serum proteomic pattern and cytokine concentration in cancer patients during chemotherapy--preliminary results. Biomed Pharmacother (2006) 0.82
Serum albumin fragmentation in end-stage renal disease patients--a pilot study. Clin Chem Lab Med (2009) 0.78
Nephrotoxicity due to combination antibiotic therapy with vancomycin and aminoglycosides in septic critically ill patients. Chemotherapy (2006) 0.76
Outcomes of Vascular Access Care and Surgery Managed by Interventional Nephrologists: A Twelve-Year Experience. Blood Purif (2016) 0.75
[Protein-energy wasting and nutritional supplementation in chronic hemodialysis]. G Ital Nefrol (2015) 0.75
Performance evaluation of the Vitros(®)3600 immunodiagnostic system for the determination of free thyroid hormones. Clin Chem Lab Med (2011) 0.75
The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis. Blood Purif (2015) 0.75
Reflectance confocal microscopy features of seborrheic dermatitis for plaque psoriasis differentiation. Dermatology (2014) 0.75
Concordance between in vivo reflectance confocal microscopy and optical histology of lymphomatoid papulosis. Skin Res Technol (2013) 0.75
Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. J Nephrol (2004) 0.75